|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
STOK | Liau Gene | EVP Research & Preclinical Dev | Dec 28 | Option Exercise | 0.60 | 8,000 | 4,800 | 21,500 | Mar 04 05:00 PM |
STOK | Liau Gene | EVP Research & Preclinical Dev | Mar 02 | Option Exercise | 0.60 | 5,195 | 3,117 | 26,546 | Mar 04 05:00 PM |
STOK | Liau Gene | EVP Research & Preclinical Dev | Mar 02 | Sale | 63.05 | 5,195 | 327,546 | 21,351 | Mar 04 05:00 PM |
STOK | Liau Gene | EVP Research & Preclinical Dev | Dec 28 | Sale | 58.73 | 149 | 8,751 | 21,351 | Mar 04 05:00 PM |
STOK | Liau Gene | EVP Research & Preclinical Dev | Oct 16 | Option Exercise | 0.60 | 5,851 | 3,511 | 19,351 | Oct 20 04:52 PM |
STOK | Liau Gene | EVP Research & Preclinical Dev | Oct 19 | Option Exercise | 0.67 | 32,000 | 21,590 | 45,500 | Oct 20 04:52 PM |
STOK | Liau Gene | EVP Research & Preclinical Dev | Oct 19 | Sale | 37.82 | 32,000 | 1,210,164 | 13,500 | Oct 20 04:52 PM |
STOK | Liau Gene | EVP Research & Preclinical Dev | Oct 16 | Sale | 40.00 | 5,851 | 234,042 | 13,500 | Oct 20 04:52 PM |
STOK | Liau Gene | EVP Research & Preclinical Dev | Oct 13 | Option Exercise | 0.60 | 1,649 | 989 | 15,149 | Oct 13 05:43 PM |
STOK | Liau Gene | EVP Research & Preclinical Dev | Oct 13 | Sale | 40.00 | 1,649 | 65,960 | 13,500 | Oct 13 05:43 PM |
STOK | Liau Gene | EVP Research & Preclinical Dev | Jun 01 | Option Exercise | 2.19 | 20,000 | 43,800 | 33,500 | Jun 03 04:57 PM |
STOK | Liau Gene | EVP Research & Preclinical Dev | Jun 01 | Sale | 26.35 | 20,000 | 527,037 | 13,500 | Jun 03 04:57 PM |
STOK | Liau Gene | EVP Research & Preclinical Dev | May 22 | Option Exercise | 0.60 | 7,500 | 4,500 | 21,000 | May 26 05:58 PM |
STOK | Liau Gene | EVP Research & Preclinical Dev | May 22 | Sale | 30.00 | 7,500 | 225,000 | 13,500 | May 26 05:58 PM |
STOK | Liau Gene | EVP Research & Preclinical Dev | Dec 20 | Option Exercise | 0.60 | 6,000 | 3,600 | 6,000 | Apr 15 07:33 PM |
STOK | Liau Gene | EVP Research & Preclinical Dev | Mar 31 | Option Exercise | 0.60 | 7,500 | 4,500 | 13,500 | Apr 15 07:33 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite